US-based Cohere Health has launched a Global Capability Centre in Hyderabad, positioning India as a core element of its global operating model for AI-powered clinical intelligence solutions. The facility will evolve into a centre of excellence, integrating AI and machine learning engineering, analytics, clinical operations and product teams to enhance decision-making for health plans, clinicians and patients worldwide. By bridging clinical expertise with advanced AI, the GCC aims to streamline payer-provider interactions, accelerate product advancements and deliver scalable solutions that improve care access and outcomes.
For healthcare technology leaders, this move exemplifies how GCCs are transitioning from cost centres to innovation hubs, leveraging India’s engineering talent to address complex challenges in prior authorisation, payment integrity and utilisation management. In India’s burgeoning digital health ecosystem, where AI adoption is accelerating amid regulatory pushes for data interoperability, Cohere’s investment signals confidence in local capabilities to handle sensitive clinical datasets and domain-specific model training at enterprise scale.
Leadership vision and operational integration
Siva Namasivayam, CEO and co-founder, described the GCC as instrumental in fusing AI-driven clinical intelligence with India’s talent pool to drive better payer-provider collaboration and patient outcomes globally. Himanshu Gandhi, Site General Manager for Cohere Health India, emphasised a culture that merges clinical depth with AI engineering to support responsible, large-scale solutions. These teams will collaborate closely with U.S. counterparts, expanding capacity across engineering, product development, data science and compliance to meet surging demand for connected healthcare platforms.
This distributed model reduces latency in iteration cycles for AI models trained on clinical data, enabling faster refinement of algorithms that optimise prior authorisations and reduce administrative burdens. Indian enterprises in healthtech stand to benefit indirectly, as global standards for AI ethics and clinical validation emerging from such centres could influence domestic telemedicine and insurance tech deployments.
Strategic hiring and future expansion trajectory
Cohere plans aggressive hiring in Hyderabad across AI/ML engineering, payment integrity, clinical operations and data science to strengthen its platform’s scalability and clinical impact. This expansion responds to growing needs for AI solutions that navigate regulatory complexities in healthcare reimbursement and provider workflows. By embedding clinical operations alongside engineering, the GCC ensures that AI outputs remain grounded in real-world medical protocols, mitigating risks of hallucination or bias in high-stakes decisions.
For policy makers and investors, the initiative reinforces Hyderabad’s emergence as a healthtech GCC hotspot, complementing clusters in Bengaluru and Chennai with specialised clinical AI focus. It also highlights how U.S. firms are using Indian centres to operationalise generative AI in regulated domains, potentially accelerating talent upskilling in healthcare informatics nationwide.
Implications for India’s healthtech ecosystem
The Hyderabad GCC positions Cohere to capitalise on demand for solutions that harmonise payer economics with provider efficiency, a pain point in fragmented markets like India’s insurance and hospital sectors. As health plans worldwide grapple with rising costs and utilisation pressures, clinically trained AI from distributed teams could standardise processes, cutting approval times and error rates. In the Indian context, this model offers a blueprint for local startups to integrate AI into Ayushman Bharat Digital Mission frameworks, fostering interoperability between public schemes and private payers.
Overall, Cohere’s commitment underscores that India is not merely an offshore extension but a strategic partner in building resilient, AI-native healthcare infrastructure capable of global deployment.
